Product Launch, Quarterly Reports, Executive Change, and Partnership -
Research Report on Medtronic, WellPoint, Centene, Align Technology, and
Editor Note: For more information about this release, please scroll to bottom.
NEW YORK, November 1, 2013
NEW YORK, November 1, 2013 /PRNewswire/ --
Today, Analysts' Corner announced new research reports highlighting Medtronic,
Inc. (NYSE: MDT), WellPoint Inc. (NYSE: WLP), Centene Corp. (NYSE: CNC), Align
Technology Inc. (NASDAQ: ALGN), and WellCare Health Plans, Inc. (NYSE: WCG).
Today's readers may access these reports free of charge - including full price
targets, industry analysis and analyst ratings - via the links below.
Medtronic, Inc. Research Report
On October 21, 2013, Medtronic, Inc. (Medtronic) announced the launch of the
Export Advance aspiration catheter, which offers greater power and superior
deliverability, in the US. Jason Weidman, Vice President and General Manager
of Medtronic's Coronary business, stated, "With more than 10 years of market
leadership in this product category, Medtronic has continued to lead the way
in innovation, setting a new standard of performance with the Export Advance
aspiration catheter." Weidman continued, "In addition to superior
deliverability, our next-generation device offers high-performing aspiration
power that physicians have come to expect from Export aspiration catheters,
which to date have been used to treat more than one million patients
worldwide." The Full Research Report on Medtronic, Inc. - including full
detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:
WellPoint Inc. Research Report
On October 23, 2013, WellPoint Inc. (WellPoint) released its Q3 2013 results.
For Q3 2013, WellPoint registered total revenues of $18.0 billion, up 17.0%
YoY. The Company posted net income of $656.2 million in Q3 2013, compared to
net income of $691.2 million in Q3 2012. WellPoint reported diluted EPS of
$2.16, up 0.5% YoY during the quarter. Wayne DeVeydt, Executive Vice President
and Chief Financial Officer of WellPoint, commented, "Our third quarter
results were driven primarily by lower than anticipated medical cost
experience, as well as favorable membership and revenue. Our results were also
supported by strong operating cash flow generation." The Full Research Report
on WellPoint Inc. - including full detailed breakdown, analyst ratings and
price targets - is available to download free of charge at:
Centene Corp. Research Report
On October 22, 2013, Centene Corp. (Centene) released its Q3 2013 results.
Centene registered total revenues of $2.8 billion in Q3 2013, up 14.5% YoY.
The Company posted net earnings attributable to Centene of $49.4 million in Q3
2013, up 1192.8% YoY. Centene further reported diluted EPS of $0.87 in Q3
2013, up 1142.9% YoY. Commenting on the results, Michael F. Neidorff,
Centene's Chairman and CEO, said, "The quarter and year to date results
reflect the efforts and growing capabilities of all our employees who are
committed to delivering high quality and lower cost services." The Full
Research Report on Centene Corp. - including full detailed breakdown, analyst
ratings and price targets - is available to download free of charge at:
Align Technology Inc. Research Report
On October 28, 2013, Align Technology Inc. (Align Technology) announced the
resignation of Richard Twomey from the position of Vice President,
International to serve as President and CEO of a leading global healthcare
products and services company based in Europe. According to Align Technology,
Thomas M. Prescott, Align's President and CEO, will assume primary
responsibility for all international operations. Prescott commented, "On
behalf of Align's executive management team and board of directors, I want to
thank Richard for his leadership in the growth and development of our
international business and congratulate him on this new career opportunity."
He added, "We have a world-class team at Align, including a strong global team
with seasoned, experienced leaders who are driving our European growth and
expansion in Asia. I am confident this organization will continue to deliver
great results in our international markets." The Full Research Report on Align
Technology Inc. - including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:
WellCare Health Plans, Inc. Research Report
On October 21, 2013, WellCare Health Plans, Inc. (WellCare) announced its
partnership with Louisiana's Smoking Cessation Trust (SCT) to encourage its
eligible Louisiana Medicare Advantage members to enroll in a no-cost, smoking
cessation program. Frank Heyliger, WellCare's Region President for Louisiana
and Texas, said, "WellCare's mission is to enhance our members' health and
quality of life." Heyliger continued, "We see our partnership with the SCT as
a great opportunity to help our members access the critical services they may
need to kick the smoking habit for good. This can lead to improvements in
chronic health conditions and positively impact overall health outcomes." The
Full Research Report on WellCare Health Plans, Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at: [http://www.AnalystsCorner.com/r/full_research_report/be48_WCG]
1.This is not company news. We are an independent source and our views do
not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
only human and are prone to make mistakes. If you notice any errors or
omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
increase awareness for mentioned companies to our subscriber base and the
4.If you wish to have your company covered in more detail by our team, or
wish to learn more about our services, please contact us at
5.For any urgent concerns or inquiries, please contact us at
6.Are you a public company? Would you like to see similar coverage on your
company? Send us a full investors' package to
research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
SOURCE Analysts' Corner
Contact: Joe Thomas; +1-310-496-8071 (North America)
Press spacebar to pause and continue. Press esc to stop.